Senti Biosciences Holdings, Inc.
For the period ended Oct 21, 2026. Filed Oct 26, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 21, 2026 · Filed Oct 26, 2026
Use the contents to explore the available documents and sections.
Contents
EX-99.1 · Reverse Stock Split
Reverse Stock Split
The Company’s stockholders approved a reverse stock split of the Company’s common stock at a ratio within the range of 1-for-20 to 1-for-50, as determined by the board of directors. The reverse stock split remains subject to the Company’s board determining to implement the reverse stock split and is not reflected in the pro forma adjustments included in Note 2 below.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.